Prof. Dr. Dr. Flavio Forrer
Leiter Nuklearmedizin
Leitende(r) Arzt/Ärztin
Radiologie und Nuklearmedizin · Dept. IV
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys
Müller C, Schibli R, Forrer F, Krenning E, de Jong M. Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys. Nucl Med Biol 2007; 34:603-8.
01.08.2007Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys
01.08.2007Nucl Med Biol 2007; 34:603-8
Müller Cristina, Schibli Roger, Forrer Flavio, Krenning Eric P, de Jong Marion
Is it possible to predict renal function in small animals using a multi-pinhole SPECT system
Forrer F, Rolleman E, Schramm N, Krenning E, de Jong M. Is it possible to predict renal function in small animals using a multi-pinhole SPECT system. Eur J Nucl Med Mol Imaging 2007; 34:1127-8.
01.07.2007Is it possible to predict renal function in small animals using a multi-pinhole SPECT system
01.07.2007Eur J Nucl Med Mol Imaging 2007; 34:1127-8
Forrer Flavio, Rolleman E, Schramm N, Krenning E P, de Jong M
Neuroendocrine tumors. Peptide receptor radionuclide therapy
Forrer F, Valkema R, Kwekkeboom D, de Jong M, Krenning E. Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007; 21:111-29.
01.03.2007Neuroendocrine tumors. Peptide receptor radionuclide therapy
01.03.2007Best Pract Res Clin Endocrinol Metab 2007; 21:111-29
Forrer Flavio, Valkema Roelf, Kwekkeboom Dik J, de Jong Marion, Krenning Eric P
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
Müller C, Forrer F, Bernard B, Melis M, Konijnenberg M, Krenning E, de Jong M. Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs. Cancer Biother Radiopharm 2007; 22:151-9.
01.02.2007Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
01.02.2007Cancer Biother Radiopharm 2007; 22:151-9
Müller Cristina, Forrer Flavio, Bernard Bert F, Melis Marleen, Konijnenberg Mark, Krenning Eric P, de Jong Marion
From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging
Forrer F, Rolleman E, Bijster M, Melis M, Bernard B, Krenning E, de Jong M. From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging. Cancer Biother Radiopharm 2007; 22:40-9.
01.02.2007From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging
01.02.2007Cancer Biother Radiopharm 2007; 22:40-9
Forrer Flavio, Rolleman Edgar, Bijster Magda, Melis Marleen, Bernard Bert, Krenning Eric P, de Jong Marion
Anaphylactoid reaction from amifostine
Rolleman E, Forrer F, Deckers J, de Groot H, Valkema R, de Jong M, Krenning E. Anaphylactoid reaction from amifostine. Radiother Oncol 2006; 82:110-1; author reply 111.
20.12.2006Anaphylactoid reaction from amifostine
20.12.2006Radiother Oncol 2006; 82:110-1; author reply 111
Rolleman Edgar J, Forrer Flavio, Deckers Jaap, de Groot Hans, Valkema Roelf, de Jong Marion, Krenning Eric P
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Rolleman E, Forrer F, Bernard B, Bijster M, Vermeij M, Valkema R, Krenning E, de Jong M. Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate. Eur J Nucl Med Mol Imaging 2006; 34:763-771.
05.12.2006Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
05.12.2006Eur J Nucl Med Mol Imaging 2006; 34:763-771
Rolleman Edgar J, Forrer Flavio, Bernard Bert, Bijster Magda, Vermeij Marcel, Valkema Roelf, Krenning Eric P, de Jong Marion
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals
Forrer F, Valkema R, Bernard B, Schramm N, Hoppin J, Rolleman E, Krenning E, de Jong M. In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals. Eur J Nucl Med Mol Imaging 2006; 33:1214-7.
11.07.2006In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals
11.07.2006Eur J Nucl Med Mol Imaging 2006; 33:1214-7
Forrer Flavio, Valkema R, Bernard B, Schramm N U, Hoppin J W, Rolleman E, Krenning E P, de Jong M
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors
Forrer F, Waldherr C, Maecke H, Mueller-Brand J. Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors. Anticancer Res 2006; 26:703-7.
01.01.2006Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors
01.01.2006Anticancer Res 2006; 26:703-7
Forrer Flavio, Waldherr Christian, Maecke Helmut R, Mueller-Brand Jan
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene
Schiavi F, Välimäki M, Kawecki A, Szutkowski Z, Schipper J, Walz M, Pigny P, Bauters C, Willet-Brozick J, Baysal B, Januszewicz A, Eng C, Opocher G, Neumann H, Forrer F, Walter M, Boedeker C, Bausch B, Peçzkowska M, Gomez C, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann M, Berlis A, Brink I, Cybulla M, Muresan M, European-American Paraganglioma Study Group. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005; 294:2057-63.
26.10.2005Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene
26.10.2005JAMA 2005; 294:2057-63
Schiavi Francesca, Välimäki Matti, Kawecki Andrzej, Szutkowski Zbigniew, Schipper Jörg, Walz Martin K, Pigny Pascal, Bauters Catherine, Willet-Brozick Joan E, Baysal Bora E, Januszewicz Andrzej, Eng Charis, Opocher Giuseppe, Neumann Hartmut P H, Forrer Flavio, Walter Martin A, Boedeker Carsten C, Bausch Birke, Peçzkowska Mariola, Gomez Clara Fuentes, Strassburg Thomas, Pawlu Christian, Buchta Mary, Salzmann Maren, Hoffmann Michael M, Berlis Ansgar, Brink Ingo, Cybulla Markus, Muresan Mihaela, European-American Paraganglioma Study Group
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC
Forrer F, Uusijärvi H, Storch D, Maecke H, Mueller-Brand J. Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC. J Nucl Med 2005; 46:1310-6.
01.08.2005Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC
01.08.2005J Nucl Med 2005; 46:1310-6
Forrer Flavio, Uusijärvi Helena, Storch Daniel, Maecke Helmut R, Mueller-Brand Jan
Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours
Forrer F, Mueller-Brand J, Maecke H. Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2005; 32:511-2; author reply 513.
01.04.2005Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours
01.04.2005Eur J Nucl Med Mol Imaging 2005; 32:511-2; author reply 513
Forrer Flavio, Mueller-Brand J, Maecke H
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
Forrer F, Uusijärvi H, Waldherr C, Cremonesi M, Bernhardt P, Mueller-Brand J, Maecke H. A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2004; 31:1257-62.
10.06.2004A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
10.06.2004Eur J Nucl Med Mol Imaging 2004; 31:1257-62
Forrer Flavio, Uusijärvi H, Waldherr C, Cremonesi M, Bernhardt P, Mueller-Brand J, Maecke H R
[Schizophrenia in the German national paper Frankfurter Allgemeine Zeitung -- a didactic play]
Hoffmann-Richter U, Forrer F, Finzen A. [Schizophrenia in the German national paper Frankfurter Allgemeine Zeitung -- a didactic play]. Psychiatr Prax 2003; 30:4-7.
01.01.2003[Schizophrenia in the German national paper Frankfurter Allgemeine Zeitung -- a didactic play]
01.01.2003Psychiatr Prax 2003; 30:4-7
Hoffmann-Richter Ulrike, Forrer Flavio, Finzen Asmus